Terms and Conditions
SECTION 1 – PURPOSE, SCOPE & DEFINITIONS

1. PURPOSE, SCOPE & CONTRACTUAL FRAMEWORK

1.1 Purpose of Agreement
This Terms‑and‑Conditions document (“Agreement”) establishes the entire contractual relationship between Savage Silverback Labz (“Savage Silverback Labz,” “we,” “our,” or “us”) and any natural or legal person (“Customer,” “you,” or “your”) that, whether directly or through an agent or affiliate:

visits, browses, or otherwise interacts with the website savagesilveerbacklabz.com (the “Site”);

downloads, streams, or otherwise accesses any digital asset, file, or software module furnished by us; or

inquires about, requests a quotation for, purchases, receives, stores, formulates, analyses, combines, transfers, exports, or disposes of any Product (as defined below).

The Agreement applies universally to every e‑mail, telephone call, instant‑message, video conference, pro‑forma invoice, quotation, sample dispatch, consultation, purchase order, sales order, license of documentation, or other transaction or communication with Savage Silverback Labz, unless superseded by a later, separately executed written agreement signed by a duly authorized officer of Savage Silverback Labz that expressly states it overrides this Agreement. Acceptance of or payment for any Product, or continued use of the Site after notice of these Terms, constitutes Customer’s unqualified assent to be bound hereby.

1.2 Scope of Covered Items (“Products”)
“Products” shall be interpreted in the broadest possible sense and includes, without limitation:

(a) Peptide‑Based Materials – linear, cyclic, branched, stapled, or otherwise modified peptides; peptidomimetics; amino‑acid derivatives; oligonucleotide–peptide conjugates; isotope‑labelled analogues; metabolites; pro‑drugs; protecting‑group intermediates; resin‑bound precursors; proprietary scaffolds; and any salt, ester, hydrate, solvate, or polymorphic form thereof.

(b) Research & Process Intermediates – custom‑synthesis building blocks, process development samples, forced‑degradation by‑products, impurity markers, reference standards, and structural isomers supplied for method development, stability studies, or analytical calibration.

(c) Ancillary Deliverables – all data and documentation accompanying or relating to the foregoing, including but not limited to certificates of analysis (CoAs), safety data sheets (SDSs), chromatograms, spectra, batch records, technical manuals, operating procedures, and structure files—whether delivered in hard copy, PDF, machine‑readable, or cloud‑hosted form.

(d) Digital & Intangible Assets – any software, spectral database, calculator, algorithm, API key, or downloadable toolkit provided through the Site or by e‑mail. For intellectual‑property and licensing purposes, such digital assets are treated as “Products,” though they may not constitute “chemical substances” for regulatory filings.

(e) Embodiments & Derivatives – any mixture, formulation, conjugate, article, or derivative in which a Product remains recognizable or traceable to its Savage Silverback Labz origin until final consumption, dilution below analytical detection, or lawful disposal.

Unless expressly agreed otherwise, Products may be supplied neat, lyophilized, in solution, adsorbed to solid support, encapsulated in a kit, or presented as part of a combinatorial library, regardless of purity grade, quantity, or delivery vector. The definition is intended to be exhaustive; ambiguity is resolved in favor of inclusion.

1.3 Hierarchy of Contractual Documents
If any term in another document conflicts with this Agreement, the following descending order of precedence governs:

(a) A separately executed master supply, services, or license agreement (if any) that expressly overrides these Terms;
(b) A written Sales Order Confirmation (“SOC”) or amendment, signed (physically or electronically) by an authorized Savage Silverback Labz officer, that modifies specified clauses for the referenced order only;
(c) This Agreement, including all sections, definitions, schedules, attachments, footnotes, and policies incorporated by URL, hyperlink, or explicit reference (e.g., Shipping, Returns & Refunds Policy);
(d) The most recent quotation, pro‑forma invoice, scope‑of‑work, or technical proposal issued by Savage Silverback Labz;
(e) Any standard terms or conditions pre‑printed on, linked from, or referenced in Customer’s purchase order, procurement portal, or other form — all of which are hereby objected to and rejected in their entirety, except solely as to non‑commercial particulars needed for fulfilment (catalogue number, quantity, ship‑to address, preferred delivery date, and freight instructions).

No communication from sales representatives, technical staff, or customer‑service personnel—oral or written—shall modify the Agreement or create any warranty, obligation, or liability unless set forth in a document ranked (a) or (b) above.

1A – RESEARCH‑USE‑ONLY (RUO) DESIGNATION FOR PEPTIDES

(a) Regulatory Classification. All Products are furnished solely under a “Research Use Only” (“RUO”) exemption within the meaning of:

United States: FDA Guidance “Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only” (2013) and 21 C.F.R. § 809.10(c)(2); Toxic Substances Control Act (TSCA) § 5(h)(3) research‑and‑development exemption; Federal Food, Drug, and Cosmetic Act §§ 201(g) & 505; Drug Quality and Security Act (DQSA) §§ 503A/B (peptide compounding exclusion).

European Union / EEA: REACH Regulation (EC) 1907/2006, Article 3(23) (scientific research and development) and Article 9 (product‑and‑process‑oriented research and development, “PPORD”) five‑year notification exemption, renewable; CLP Regulation (EC) 1272/2008 labelling; Directive 2001/83/EC on medicinal products (human) and Regulation (EC) 2019/6 (veterinary).

OECD Countries: OECD Principles of Good Laboratory Practice (GLP, most recent revision) for non‑clinical safety studies.

International: UN GHS Rev. 9 hazard communication; 1988 UN Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances (schedule analogues); WADA Prohibited List (peptide growth factors).

The RUO status prohibits any clinical, veterinary, diagnostic, therapeutic, aesthetic, performance‑enhancement, agricultural, or consumer use—even on a “compassionate,” “pilot,” or “educational” basis.

(b) Mandatory Label & Disclaimer. Every vial, kit, outer carton, CoA, SDS, quotation, and invoice bears the legend:

FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY USE.
NOT FOR DIAGNOSTIC, THERAPEUTIC, COMPOUNDING, OR CONSUMER APPLICATIONS.

(c) Customer’s Regulatory Obligations. Customer must:

Verify whether an RUO substance is listed on the TSCA Chemical Substance Inventory or, for EEA imports, submit a PPORD notification or obtain a REACH registration/authorization or other national waiver.
Screen each peptide against the U.S. Controlled Substances Act schedules, EU psychotropic substances lists, and WADA Prohibited List. If scheduled, Customer must possess and maintain all requisite DEA, Home Office, or equivalent licences.
Ensure that any animal or ex‑vivo work complies with the Animal Welfare Act (US) or Directive 2010/63/EU, and that institutional animal‑care and biosafety committees have approved a protocol explicitly covering the RUO peptide.
Maintain, for a minimum of ten (10) years, batch‑level receipt, storage, inventory, analytical, usage, and disposal records sufficient to trace each product from acquisition to final fate and to demonstrate compliance to competent authorities upon request.
Refrain from re‑packaging, re‑labelling, compounding, encapsulating, sterilising, formulating for injection, topical application, or oral dosing, or otherwise preparing any dosage form intended for or capable of administration to humans or animals.
Immediately notify Purified Aminos if the RUO peptide will be shipped, transferred, or disclosed to any third party, and furnish end‑user certification and export‑licence documentation in advance.
(d) Consequences of Misuse. A Customer’s violation of subsection (c) constitutes a material breach. Savage Silverback Labz may (i) cancel outstanding orders, (ii) blacklist the Customer entity and its affiliates, (iii) report the violation to FDA, DEA, EU national competent authorities, customs, WADA, or other regulators, and (iv) pursue indemnity for all resulting penalties, recall expenses, and reputational harm.

SECTION 2 – ELIGIBILITY, CREDENTIALS & CUSTOMER REPRESENTATIONS

2.1 Qualified Personnel Standard. Customer warrants that each individual who will order, receive, store, handle, test, or dispose of a Product:

is at least twenty‑one (21) years of age;

has completed, at a minimum, documented training in chemical hygiene, safe handling of hazardous materials, and basic biosafety (e.g., OSHA 29 C.F.R. § 1910.1450 or equivalent);

understands how to interpret SDS hazard statements, personal‑protective‑equipment (PPE) requirements, and disposal instructions; and

is either (a) an employee of, or consultant to, a licensed commercial R&D laboratory, accredited academic institution, hospital research division, contract research organization (CRO), or government agency; or (b) a fiduciary officer of the Customer entity expressly authorized to bind the entity to this Agreement.

2.2 Institutional Authorizations. Customer affirms that its facility (and any affiliate or subcontractor facility that will handle the Products) possesses and will maintain:

current local business licenses, tax registrations, and zoning approvals for chemical research activities;

applicable DEA registrations, state controlled‑substances permits, or international drug precursors licenses, where required;

any Institutional Biosafety Committee, Institutional Animal Care and Use Committee, or Environmental Health & Safety approvals necessary for the proposed research; and

an emergency‑response plan, spill‑response kit, and written standard‑operating procedures (SOPs) covering receipt, labelling, segregation, PPE, engineering controls, accidental exposure, and final disposal of RUO peptides.

2.3 Accuracy of Information. All declarations, end‑use statements, import identifiers, tax exemption certificates, and analytical data you submit are true, correct, and complete. Submission of false, forged, or misleading documentation constitutes fraud and grounds for immediate termination of this Agreement.

2.4 Indemnification & Duty to Defend. Customer shall defend, indemnify, and hold harmless Savage Silverback Labz, its parent, affiliates, managers, members, and employees against any suit, claim, governmental action, loss, or expense (including reasonable attorneys’ fees) arising out of: (i) any breach of Sections 1A or 2; (ii) any injury, illness, or property damage caused by a Product after title passes; or (iii) any infringement or alleged infringement of third‑party intellectual‑property rights resulting from Customer’s formulation, modification, or downstream use of a Product.

SECTION 3 – ORDERS, PRICING & PAYMENT

3.1 Offer, Acceptance, and Contract Formation
(a) All catalog prices, stock indicators, and estimated lead‑times displayed on the Site, in e‑mail, or in marketing literature are invitations to treat and do not bind Purified Aminos. Customer’s purchase order constitutes an offer. A contract (“Confirmed Order”) arises only when Savage Silverback Labz issues a written Sales Order Confirmation (SOC) referencing the Customer’s order number and signed electronically by an authorised representative.
(b) Any Customer terms printed on or attached to the purchase order are expressly rejected unless Purified Aminos accepts them in writing.

3.2 Pricing, Currency, and Taxes
(a) All prices are quoted and payable in United States dollars (USD) unless the SOC specifies another currency.
(b) Prices exclude sales/use tax, value‑added tax (VAT/GST), customs duties, excise, brokerage, hazmat surcharge, cold‑chain fees, and insurance (“Taxes & Duties”). Customer shall pay all such amounts or provide a valid, jurisdiction‑specific exemption certificate before shipment.
(c) Where delivery is scheduled more than thirty (30) days after SOC issuance, Savage Silverback Labz may adjust the price to pass through documented increases in peptide raw materials, solvents, energy, regulatory fees, or transport costs. Customer may cancel the affected line item within five (5) Business Days of notice; absent objection, the revised price is deemed accepted.

3.3 Accepted Payment Methods & Security
(a) We accept: (i) Visa, Mastercard, American Express, and Discover cards processed via a PCI‑DSS Level 1 gateway; (ii) ACH or wire transfers to a designated U.S. or Nevis account; and (iii) blockchain‑verified cryptocurrency (BTC, ETH, USDT‑TRC20/ERC‑20) routed through a FATF Travel‑Rule‑compliant virtual‑asset‑service provider.
(b) Card transactions use 3‑D Secure and Address‑Verification Service (AVS). Purified Aminos never stores full card numbers on its servers.
(c) Cryptocurrency transactions are considered final when a minimum of six (6) network confirmations are recorded. Cryptocurrency received after the stated quotation validity period may require a balance‑payment adjustment.

3.4 Finality of Sale & Cancellation
Because Products are perishable, custom‑synthesized, or subject to tight chain‑of‑custody controls, all Confirmed Orders are non‑cancellable and non‑refundable once the payment gateway returns an “Approved” response, except with Savage Silverback Labz written consent and payment of:
(i) 100 % of incurred raw‑material and labor costs;
(ii) 50 % of the remaining line‑item value for work‑in‑process; and
(iii) any third‑party cancellation penalties (e.g., carrier dry‑ice surcharges).

3.5 Late Payment, Collection Costs & Chargebacks
(a) Unpaid or partially paid invoices accrue interest from the due date at one and one‑half percent (1.5 %) per month, compounded monthly, or the maximum rate allowed by applicable law, whichever is lower.
(b) Savage Silverback Labz may, without liability, suspend open orders, convert future orders to cash‑in‑advance, or require a standby letter of credit if Customer’s creditworthiness deteriorates.
(c) Initiating a credit‑card chargeback, ACH reversal, or cryptocurrency refund request without first submitting a support ticket through savagesilverbacklabz.com/contact and allowing fourteen (14) calendar days for investigation constitutes a material breach. Customer must immediately (i) reimburse the disputed amount, (ii) pay all card‑network/ bank penalties, and (iii) reimburse Savage Silverback Labz for reasonable collection costs, attorney fees, and a USD $2,500 liquidated‑damages fee per occurrence.

3.6 Anti‑Fraud, Anti‑Money‑Laundering, and KYC Screening
Savage Silverback Labz performs automated and manual screening to satisfy OFAC, EU, U.K., UN, and Nevis sanctions compliance, and reserves the right to:

decline or hold orders originating from anonymizing proxies, sanctioned jurisdictions, or high‑risk addresses (e.g., freight‑forwarder lockers, hotels, residential drop‑boxes);

request government‑issued photo ID, proof of legal entity registration, beneficial‑ownership declarations, or blockchain‑forensics transaction reports;

cancel any order that, in Savage Silverback Labz’ sole judgment, poses an elevated risk of diversion, financial crime, or regulatory breach.

Failure to supply requested KYC documentation within forty‑eight (48) hours is grounds for immediate cancellation with forfeiture of any amounts paid.

4. SHIPMENT, TITLE, RISK OF LOSS & DELIVERY CONDITIONS

4.1 Applicable Incoterm. Unless the Sales Order Confirmation (“SOC”) expressly provides otherwise, every shipment is made FCA Savage Silverback Labz, ). Customer selects the mode of transport from the options we offer and instructs the carrier on its own behalf; Savage Silverback Labz merely tenders the goods—properly packed, labelled, and customs‑ready—to the carrier or to the freight forwarder named by Customer.

4.2 Passage of Title & Risk. Full legal and equitable title to, and every risk of loss, theft, delay, contamination, degradation, seizure, or mis‑delivery in the Products pass to Customer immediately upon the earlier of (a) the carrier’s signature on the waybill, or (b) handover to Customer’s agent at our dock. After that moment Savage Silverback Labz has no liability whatsoever for the shipment or its condition. Customer is responsible for purchasing cargo insurance if desired.

4.3 Cold‑Chain & Special Handling. Temperature‑sensitive consignments ship with dry ice, phase‑change gel packs, or liquid nitrogen dewars rated for the quoted transit time. Because dry ice sublimates and dewars vent, Savage Silverback Labz does not guarantee that internal temperatures will remain within any specific range once risk has passed. Carrier delay, customs inspection, force majeure, or Customer’s failure to collect the parcel promptly may compromise product integrity and does not entitle Customer to refund, replacement, or credit.

4.4 Importer‑of‑Record Duties. Customer (or its nominated customs broker) acts as the sole importer of record and accepts all responsibility for: customs entries; Harmonized System (HS) code verification; licences or permits; controlled‑substance clearances; veterinary, phytosanitary, or FDA notices; payment of duties, taxes, brokerage, harbor fees, or anti‑dumping levies; and post‑entry amendments or audits. Purified Aminos will furnish commercial invoice, packing list, and certificate of origin but bears no liability for classification errors, missed deadlines, or penalties.

4.5 Delivery Addresses & Refusal of Service. Savage Silverback Labz may refuse, cancel, or hold shipments to high‑risk or non‑fixed addresses—including hotels, co‑working spaces, PO boxes, freight‑forwarder lockers, and re‑shipping depots—in its sole discretion. We may blacklist any Customer that provides an address known to be associated with diversion, fraud, or regulatory violations.

4.6 Partial Shipments & Back‑Orders. We may fulfil a Confirmed Order in multiple installments. Each installment is treated as a separate contract for title‑transfer, risk, invoicing, and payment purposes. Delay or defect in one installment does not entitle Customer to cancel the balance.

4.7 Force Majeure. The quoted ship or arrival date is a non‑binding estimate. Savage Silverback Labz is excused, without liability, for any delay or non‑performance caused by events beyond its reasonable control—including but not limited to strikes, carrier capacity shortages, port congestion, cyber‑attack, severe weather, natural disaster, armed conflict, embargo, pandemic, or governmental action.

4.8 Incorporation of Shipping & Returns Policy. The separate Shipping, Returns & Refunds Policy published at https://purifiedaminos.com/refund_returns/ is incorporated herein by reference. If that policy conflicts with this Section 4 or Section 5, the stricter obligation on Customer governs.

5. INSPECTION, NON‑RETURNABILITY & EXCLUSIVE REMEDY

5.1 Mandatory Incoming Inspection. Customer must inspect each shipment immediately on receipt and, within seven (7) calendar days, submit any claim for shortage, visible damage, cold‑chain breach, or mis‑pick through the support form at purifiedaminos.com/contact. The claim must include the SOC number, photographs of outer packaging, vial labels, temperature indicators (if any), and raw analytical data (HPLC, MS, NMR) supporting alleged non‑conformity. Failure to comply with this subsection constitutes irrevocable acceptance of the shipment and waiver of all claims.

5.2 Non‑Returnable, Final Sale. Because Products are perishable chemical substances requiring controlled storage—and because chain‑of‑custody cannot be re‑established once they leave our facility—ALL SALES ARE FINAL. PRODUCTS ARE SOLD “AS IS” AND MAY NOT BE RETURNED FOR CREDIT OR REFUND UNDER ANY CIRCUMSTANCE, except where Savage Silverback Labz, in its sole discretion, verifies a manufacturing defect or shipping error under § 5.3.

5.3 Exclusive Remedy for Verified Defect. If, and only if, Purified Aminos confirms that a Product fails to meet its stated purity or identity specification, or that the wrong catalogue number was shipped, Customer’s sole and exclusive remedy is—at Savage Silverback Labz option—either (a) replacement with conforming material (standard lead time applies) or (b) credit of the net invoice price toward a future purchase. Cash refunds are never available. Under no circumstance shall Savage Silverback Labz be liable for incidental, consequential, or punitive damages arising from a defective or delayed shipment.

5.4 Customer Misuse & Recall. Any use of the Products contrary to Section 1A or applicable law voids all warranties and remedies. If a governmental agency mandates, or Purified Aminos in good faith deems advisable, a recall relating to Customer’s misuse, Customer shall bear all recall costs, including notification, retrieval, destruction, and regulatory reporting. Savage Silverback Labz reserves the right to pursue full indemnification and injunctive relief.

5.5 Permanent Account Ban. Savage Silverback Labz may, without notice and at its sole discretion, suspend or terminate any Customer account and cancel or refuse future transactions for violation of this Agreement, suspected diversion, non‑payment, chargeback abuse, hostile communications, or any activity that, in Savage Silverback Labz judgment, threatens its security, reputation, or regulatory standing.

6. REGULATORY, SANCTIONS & EXPORT‑CONTROL COMPLIANCE

6.1 Restricted‑Party Screening. Customer certifies that neither it nor any parent, subsidiary, affiliate, officer, director, employee, ultimate beneficial owner, ship‑to party, or end‑user appears on: U.S. OFAC SDN List, BIS Denied Persons List, EU Consolidated Financial Sanctions List, U.K. Sanctions List, UN SCR 1267/1989/2253 lists, the Nevis FSRC sanctions schedule, or any other comparable restricted‑party list.

6.2 Destination Controls. Customer will not sell, export, re‑export, transfer, or otherwise dispose of a Product (including derivatives or formulations) to any location, entity, or person prohibited by U.S., U.K., EU, UN, or Nevis export‑control and sanctions regimes—directly or indirectly—without first obtaining all required governmental licenses and approvals.

6.3 Record‑Keeping. Customer shall maintain accurate and complete acquisition, inventory, analytical, usage, transfer, and disposal records—traceable by batch—for at least ten (10) years after the latter of (i) the date of purchase, or (ii) the date of final disposal, and shall furnish such records to Savage Silverback Labz or competent authorities upon request.

6.4 Audit & Cooperation. Upon reasonable notice, Customer will permit Savage Silverback Labz or its designee to audit regulatory records relevant to compliance with this Section 6. Non‑cooperation or audit failure constitutes material breach.

6.5 Indemnity & Enforcement. Customer shall defend, indemnify, and hold harmless Savage Silverback Labz for any fine, penalty, seizure, loss of export privileges, legal fee, or reputational damage arising from Customer’s breach of sanctions or export‑control obligations.

7. INTELLECTUAL PROPERTY & LIMITED LICENCE

7.1 Ownership of Site Content & Materials. All text, graphics, code, video, audio, photographs, data compilations, and other content on the Site, together with all trademarks, trade dress, domain names, and logos—including “Savage Silverback Labz” and any stylized variants—are the exclusive property of Savage Silverback Labzor its licensors. All rights are reserved.

7.2 Limited Browser License. Savage Silverback Labz grants Customer a non‑exclusive, non‑transferable, revocable license to display, cache, and print Site content solely for legitimate internal laboratory evaluation of Products. Customer may not copy, distribute, reverse‑engineer, decompile, create derivative works, or remove proprietary notices from any content.

7.3 Restrictions on Reverse Engineering. Customer shall not analyze the Products by peptide sequencing, mass‑spectrometric de‑novo sequencing, or other structure‑elucidation technique for the purpose of manufacturing a biosimilar or competitive product, nor cause or permit any third party to do so, without Savage Silverback Labz prior written consent.

7.4 DMCA & Injunctive Relief. Savage Silverback Labz enforces its copyrights under the Digital Millennium Copyright Act (DMCA) and is entitled to temporary, preliminary, and permanent injunctive relief without bond to stop unauthorized use of its intellectual property.

8. WEBSITE ACCEPTABLE‑USE POLICY (AUP)

8.1 Prohibited Conduct. Customer shall not, directly or through a third party:
(a) scrape, crawl, spider, or harvest data from the Site;
(b) upload, post, transmit, or link to any malicious code, ransomware, Trojan horse, or phishing scheme;
(c) conduct penetration testing, vulnerability scanning, or load testing without prior written permission;
(d) misrepresent identity, affiliation, or authority to act;
(e) forge headers, deep‑link, frame, or mirror any Site page;
(f) post, transmit, or promote defamatory, obscene, hateful, infringing, or otherwise unlawful material;
(g) circumvent, disable, or interfere with security features, access‑control mechanisms, rate‑limiters, or usage logs;
(h) use the Site to advertise or sell competitors’ products; or
(i) encourage or facilitate any violation of this Agreement.

8.2 Monitoring & Enforcement. Savage Silverback Labz may monitor Site usage, investigate suspected violations, share findings with law‑enforcement, and permanently ban any IP address, account, or organization that breaches the AUP or otherwise threatens the integrity of the Site or the safety of its users.

9. DISCLAIMERS OF WARRANTY & LIMITATION OF LIABILITY

9.1 Site Disclaimer. The Site, its servers, and all content are provided “AS IS” AND “AS AVAILABLE” without any warranty—express, implied, statutory, or otherwise—including warranties of merchantability, fitness for a particular purpose, non‑infringement, accuracy, or uninterrupted availability.

9.2 Product Disclaimer. Each Product is supplied solely as a research chemical.Savage Silverback Labz makes NO REPRESENTATION OR WARRANTY OF ANY KIND—express or implied—as to merchantability, fitness for any particular use, non‑infringement, identity, purity, stability, batch‑to‑batch consistency, or compliance with GMP, GLP, pharmacopeial monographs, or any clinical or diagnostic standard. Experimental outcomes vary and are outside Savage Silverback Labz control.

9.3 Limitation of Remedies. To the fullest extent permitted by law, Savage Silverback Labz total cumulative liability (whether in contract, tort, negligence, strict liability, or otherwise) arising out of or related to the Site, a Product, or this Agreement shall not exceed the lesser of (a) the amount Customer actually paid for the specific Product giving rise to the claim, or (b) USD $500. Savage Silverback Labz shall under no circumstance be liable for any indirect, special, incidental, punitive, exemplary, or consequential damages—including lost profits, business interruption, loss of data, or reputational harm—even if advised of the possibility of such damages or even if the limited remedy fails of its essential purpose.

10. LIMITATION OF LIABILITY

10.1 Aggregate Cap. To the fullest extent permitted by applicable law, the total cumulative liability of Savage Silverback Labz —whether in contract, warranty, tort (including negligence), strict liability, statute, misrepresentation, or any other legal theory—arising out of or relating to the Site, a Product, or this Agreement shall not exceed the lesser of (a) the amount actually paid by Customer for the specific Product or service that gave rise to the claim, or (b) USD $500.

10.2 Exclusion of Indirect Damages. IN NO EVENT shall Purified Aminos be liable for any indirect, special, incidental, consequential, exemplary, punitive, or enhanced damages of any kind—including lost profits, loss of revenue, business interruption, loss of goodwill, loss of data, cost of substitute goods, personal‑injury damages, or attorneys’ fees—even if advised of the possibility of such damages or if any limited remedy fails of its essential purpose.

10.3 No Strict Liability. Customer expressly waives any claim based on strict (no‑fault) liability for ultra‑hazardous activities or abnormally dangerous substances.

10.4 Risk Allocation. The pricing of Products reflects the risk‑allocation and liability caps set forth herein. Customer acknowledges that absent these limitations, prices would be materially higher and Savage Silverback Labz would not enter into this Agreement.

11. INDEMNIFICATION & DUTY TO DEFEND

11.1 Scope of Indemnity. Customer shall defend, indemnify, and hold harmless, Savage Silverback Labz its parent companies, subsidiaries, affiliates, directors, officers, managers, employees, agents, successors, and assigns (“Indemnitees”) from and against any and all claims, demands, suits, investigations, fines, penalties, judgments, settlements, losses, liabilities, damages, costs, and expenses (including reasonable attorneys’ and expert‑witness fees) arising out of or relating to:
(a) Customer’s purchase, receipt, possession, storage, handling, testing, formulation, use, transfer, or disposal of any Product;
(b) Customer’s breach of this Agreement, the Shipping & Returns Policy, or any linked policy;
(c) Customer’s violation of any applicable export‑control, sanctions, customs, environmental, occupational‑health, or controlled‑substances law or regulation;
(d) any actual or alleged infringement or misappropriation of third‑party intellectual‑property rights based on Customer’s modification, formulation, or downstream use of a Product; or
(e) Customer’s fraud, negligence, gross negligence, or willful misconduct.

11.2 Control of Defense. Savage Silverback Labz may elect to control its own defense and choose counsel; Customer shall cooperate fully and promptly reimburse Savage Silverback Labz for all defense costs on demand.

12. GOVERNING LAW, JURISDICTION & DISPUTE RESOLUTION

12.1 Governing Law. This Agreement is governed by and construed in accordance with the laws of the Island of Nevis, Federation of Saint Christopher and Nevis, without giving effect to conflicts‑of‑law rules and expressly excluding application of the U.N. Convention on Contracts for the International Sale of Goods (CISG).

12.2 Good‑Faith Negotiation. Before invoking arbitration, the aggrieved party must send a written notice via the contact form at savagesilverbacklabz.com/contact describing the dispute and desired relief. The parties shall confer in good faith for thirty (30) days to attempt an amicable resolution.

12.3 Binding Arbitration. If unresolved, the dispute shall be finally settled by confidential, binding arbitration under the Nevis International Arbitration Act 2018 and the UNCITRAL Arbitration Rules:

Seat & Venue: Charlestown, Nevis.
Tribunal: One (1) legally trained arbitrator fluent in English with experience in cross‑border chemical or life‑science contracts.
Language: English.
Procedure: Limited discovery proportional to the dispute; Federal Rules of Evidence (U.S.) used as persuasive authority.
Award: Reasoned award issued within nine (9) months of filing. Judgment on the award may be entered in any court of competent jurisdiction.
12.4 Injunctive Relief & IP Protection. Notwithstanding § 12.3, Savage Silverback Labz may seek preliminary or permanent injunctive relief, specific performance, or other equitable remedies in the High Court of Nevis—or any court of competent jurisdiction—to protect its intellectual property, confidential information, or compliance obligations.

12.5 Class‑Action Waiver. All proceedings shall be conducted on an individual basis. The parties waive any right to litigate or arbitrate any dispute as a class, collective, representative, or mass action.

13. FORCE MAJEURE

Savage Silverback Labz is not liable for any delay or failure in performance caused by circumstances beyond its reasonable control, including, without limitation: acts of God; earthquake; flood; hurricane; fire; lightning; explosion; pandemic; epidemic; public‑health emergency; civil unrest; war; terrorism; sabotage; armed conflict; embargo; sanctions; governmental order; labor shortage or strike; lock‑out; carrier or port congestion; supply‑chain disruption; raw‑material shortage; power outage; cyber‑attack; ransomware; or failure of telecommunications. Performance is excused for the duration of the force‑majeure event plus a commercially reasonable recovery period.

14. MODIFICATIONS OF TERMS

Savage Silverback Labz may amend this Agreement at any time by posting a revised version on the Site and updating the “Last Updated” date at the top. Changes apply prospectively only. Customer’s continued use of the Site or placement of orders after the effective date constitutes acceptance of the revised Terms. If Customer objects, its sole remedy is to cease using the Site and halt further purchases.

15. SEVERABILITY, WAIVER & ASSIGNMENT

15.1 Severability. If any provision of this Agreement is held unlawful, void, or unenforceable, that provision shall be severed or limited to the minimum extent necessary, and the remaining provisions shall remain in full force and effect.

15.2 Waiver. No waiver of any breach shall be deemed a waiver of any subsequent breach, nor shall any waiver be effective unless in writing and signed by an authorized representative of the waiving party.

15.3 Assignment. Customer may not assign, delegate, or transfer any right or obligation without Savage Silverback Labz prior written consent. Savage Silverback Labz may assign this Agreement, in whole or part, to any affiliate or successor in interest without notice.

16. ENTIRE AGREEMENT & ORDER OF PRECEDENCE

This Agreement—including the Shipping, Returns & Refunds Policy and any Sales Order Confirmation expressly incorporating or amending specific clauses—constitutes the entire understanding between the parties and supersedes all prior or contemporaneous proposals, communications, and understandings, whether oral or written, relating to its subject matter.

17. CONFIDENTIALITY & NON‑DISPARAGEMENT

17.1 Confidential Information. Customer shall keep strictly confidential all non‑public technical, commercial, pricing, or strategic information obtained from Savage Silverback Labz or ten (10) years and shall not disclose it except (i) to employees or contractors under written confidentiality obligations no less restrictive, or (ii) as required by law, in which case Customer shall give prompt notice to Purified Aminos.

17.2 Non‑Disparagement. Customer shall refrain from publishing, posting, or circulating any statement reasonably likely to harm Savage Silverback Labz reputation for product quality, regulatory compliance, or business integrity. Breach entitles Savage Silverback Labz to immediate injunctive relief and liquidated damages of USD $10,000 per offending publication, deemed a reasonable pre‑estimate of reputational injury.

18. DATA PROTECTION & PRIVACY

18.1 Legal Basis & Purpose. Purified Aminos collects and processes personal data solely for lawful purposes: order fulfilment, regulatory compliance, fraud prevention, customer support, and marketing of similar products to existing corporate customers.

18.2 International Transfers. Where Customer data include personal data subject to the EU or UK GDPR, the parties adopt the controller‑to‑processor Standard Contractual Clauses (Commission Decision 2021/914/EU) with Savage Silverback Labz place of establishment designated “Third Country: Saint Kitts and Nevis.” Supplemental technical and organizational measures include TLS encryption in transit, AES‑256 encryption at rest, and role‑based access controls.

18.3 Data Retention. Personal data are retained no longer than necessary to meet legal obligations or resolve disputes, and thereafter securely deleted or anonymized.

19. ANTI‑MONEY‑LAUNDERING (AML) & SANCTIONS SCREENING

19.1 Source of Funds. Customer certifies that all payments originate from lawful business activities and from financial institutions in jurisdictions compliant with the Financial Action Task Force (FATF) recommendations.

19.2 KYC Documentation. Savage Silverback Labz may request notarized certificates of incorporation, government‑issued photo identification, beneficial‑ownership affidavits, or blockchain‑forensics reports. Failure to supply satisfactory evidence within forty‑eight (48) hours is grounds for cancellation and permanent account ban.

20. AUDIT RIGHTS & REGULATORY CO‑OPERATION

Upon reasonable written notice, Customer shall allow Savage Silverback Labz or its qualified designee to inspect and copy records necessary to verify compliance with export‑control, RUO, environmental, safety, and anti‑diversion obligations. Customer shall also cooperate in good faith with any lawful inquiry by regulators relating to the Products.

21. PRODUCT RECALL

If any governmental authority mandates—or Savage Silverback Labz reasonably deems necessary—a recall, market withdrawal, or field correction of a Product, Customer shall:
(a) immediately cease distribution or use of affected batches;
(b) isolate and secure all remaining inventory;
(c) provide full traceability data (downstream recipients, quantities, dates); and
(d) follow Savage Silverback Labz written recall instructions promptly.
All recall costs attributable to Customer’s misuse, negligence, or regulatory non‑compliance are borne by Customer.

22. ENVIRONMENTAL COMPLIANCE & HAZARDOUS‑WASTE DISPOSAL

Customer will store, handle, transport, and dispose of all Products, derivatives, and waste streams in accordance with all applicable local, national, and international environmental laws—such as the U.S. Resource Conservation and Recovery Act (RCRA), the EU Waste Framework Directive 2008/98/EC, and the Basel Convention. Customer bears full liability for any release, contamination, cleanup cost, or regulatory penalty arising from its possession or use of the Products.

23. STATUTE OF LIMITATIONS

Any claim, dispute, or cause of action by Customer arising out of or relating to a Product, the Site, or this Agreement must be commenced within one (1) year after the date the cause of action accrues; otherwise, such claim is permanently barred. This limitation period supersedes any longer period provided by statute.

24. NO REVERSE PIERCING / ASSET‑PROTECTION PROVISION

Under Nevis law, the sole remedy of any judgment creditor against the membership interests or shares of Purified Aminos is a charging order. Foreclosure, liquidation, seizure of company assets, or any form of reverse‑piercing of the corporate veil is expressly prohibited.

25. ELECTRONIC SIGNATURES & RECORDS

Execution via DocuSign®, Adobe Sign®, or comparable e‑signature platform—or acceptance by click‑wrap or “I Agree” checkbox—constitutes a legally binding signature under the Nevis Electronic Transactions Act 2011. Electronic records are admissible as originals in any proceeding.

26. INTERPRETATION RULES

Headings are for convenience only and do not affect meaning. The singular includes the plural and vice versa. “Including,” “includes,” and “include” are deemed to be followed by “without limitation.” This Agreement shall not be construed against the drafter.

27. ACKNOWLEDGEMENT & ACCEPTANCE

BY CLICKING “I AGREE,” CHECKING A BOX, OR OTHERWISE ELECTRONICALLY SIGNING DURING CHECKOUT, YOU ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD, AND AGREE TO BE BOUND BY THESE TERMS AND CONDITIONS, INCLUDING ALL SECTIONS ABOVE.

CONTACT
All inquiries or notices under this Agreement must be submitted through the online form at savagesilverbacklabz.com/contact.

Savage Silverback Labz is a US based team delivering ≥98.5 %‑pure research peptides, powders and reagents at some of the industry’s lowest prices. Every lot is verified by accredited labs, packed in cold package, and shipped straight to your lab. When questions arise, real U.S. support answer at cs@purifiedaminos.com.

Twitter
Services
Terms of Conditions
Privacy Policy
Shipping Returns and Refunds Policy
Contact Us
Quick Links
Peptides
Liquids
Powders
COA Library
Wholesale / Kits
My account
Get In Touch
Email: info@savagesilverbacklabz.com
Address: 19615 Lone Tupelo Ct, Cypress Texas 77433
© 2025 All Rights Reserved.

All products are supplied exclusively under the RUO exemption in FDA Guidance “Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only” (2013) and 21 C.F.R. § 809.10(c)(2). They therefore fall outside FD&C Act §§ 503A/503B compounding provisions.Terms and Coniditons

“All products are sold strictly for laboratory research-use-only. They are not for human consumption, diagnostic, or therapeutic purposes.”

Statements on this Site have not been evaluated by the U.S. Food & Drug Administration. Purified Aminos is not a 503A compounding pharmacy or 503B outsourcing facility as defined in the FD&C Act.

Continued use of our Site or services constitutes your agreement to our Terms & Conditions. Any violation of those Terms will result in immediate and permanent suspension of access to all Savage Silverback Labz services, with no right of appeal.